Mednax, Inc (NYSE:MD) most recently reported quarterly actual earnings per share of $0.98 for the period ending on 2016-06-30. Prior to the company reporting, consensus estimates based on data from Zacks Research projected the company to report EPS of $1.01. The difference between the estimate and the actual EPS was $-0.03 creating a surprise factor of -2.97%. Currently, the company has an impact score of 100. The likelihood that the stock will move on news is greater with a higher impact score. According to Beta Research, the stock has a sentiment score of 0. On a scale between 1 and -1, a positive score tends to portray a favorable view of company results by news outlets. The opposite is true for a negative sentiment score.

In taking a look at where the stock might be headed, analysts have a consensus price target of $75.714 on the shares. The most bullish brokerage firm has a $80 target, while the most bearish sees the stock headed towards $70. This is according to the 7 estimates taken into consideration by Zacks Research.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2. This is according to a simplified scale where 1 represents a Strong Buy and 5 a Strong Sell recommendation. There were 7 recommendations taking into account in order to arrive at this number. Of the 7, 5 have a Strong Buy rating and 1 are rating it a Buy.


Mednax, Inc - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with’s FREE daily email newsletter.